Skip to main content
Clinical Trials/IRCT20210405050851N1
IRCT20210405050851N1
Not yet recruiting
Phase 2

Comparing of programmed intermittent epidural bolus (PIEB) with continuous epidural infusion (CEI) for labor analgesia in patients receiving epidural dexmedetomidine and Rupivacaine

Iran University of Medical Sciences0 sites60 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Iran University of Medical Sciences
Enrollment
60
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Term woman with gestational age 37 weeks or more
  • Cervical dilation Larger than 4 cm
  • Spontaneous or induced labor pain
  • Applying for epidural analgesia
  • Weight 55 to 85 kg

Exclusion Criteria

  • Patients with past medical history of sever cardiovascular diseases and bradycardia
  • Contraindication of epidural analgesia
  • Patients that are candidate for cesarean section ( multiple pregnancy , gestational age more than 37 weeks, preeclampsia , etc )
  • Patient discontent
  • Opium addiction
  • Height less than 150 cm

Outcomes

Primary Outcomes

Not specified

Similar Trials